Xiangchao Ding

525 total citations
22 papers, 403 citations indexed

About

Xiangchao Ding is a scholar working on Molecular Biology, Immunology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xiangchao Ding has authored 22 papers receiving a total of 403 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 9 papers in Immunology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xiangchao Ding's work include MicroRNA in disease regulation (5 papers), interferon and immune responses (3 papers) and Aortic Disease and Treatment Approaches (3 papers). Xiangchao Ding is often cited by papers focused on MicroRNA in disease regulation (5 papers), interferon and immune responses (3 papers) and Aortic Disease and Treatment Approaches (3 papers). Xiangchao Ding collaborates with scholars based in China and United States. Xiangchao Ding's co-authors include Chuangyan Wu, Jiahong Xia, Ping Ye, Jie Wu, Xiaofan Huang, Jiuling Chen, Shanshan Chen, Anchen Zhang, Sheng Le and Guang Li and has published in prestigious journals such as Hepatology, Scientific Reports and Arteriosclerosis Thrombosis and Vascular Biology.

In The Last Decade

Xiangchao Ding

21 papers receiving 400 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiangchao Ding China 13 214 109 98 88 65 22 403
Kaitlyn A. Sun United States 7 162 0.8× 114 1.0× 149 1.5× 70 0.8× 34 0.5× 12 432
Shubham Dubey India 7 252 1.2× 48 0.4× 107 1.1× 65 0.7× 45 0.7× 34 459
Xing Lyu China 11 191 0.9× 78 0.7× 96 1.0× 34 0.4× 32 0.5× 22 422
Anchen Zhang China 11 158 0.7× 62 0.6× 81 0.8× 113 1.3× 56 0.9× 21 346
Aline Roth Switzerland 14 171 0.8× 180 1.7× 63 0.6× 42 0.5× 144 2.2× 30 483
Nóra Béres Hungary 9 138 0.6× 90 0.8× 54 0.6× 101 1.1× 55 0.8× 20 419
Kyoko Imanaka-Yoshida Japan 6 122 0.6× 70 0.6× 51 0.5× 56 0.6× 36 0.6× 10 327
Jizhang Yu China 10 150 0.7× 85 0.8× 47 0.5× 72 0.8× 61 0.9× 22 310
Kristian L. Jones Australia 8 359 1.7× 120 1.1× 67 0.7× 51 0.6× 52 0.8× 9 602

Countries citing papers authored by Xiangchao Ding

Since Specialization
Citations

This map shows the geographic impact of Xiangchao Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiangchao Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiangchao Ding more than expected).

Fields of papers citing papers by Xiangchao Ding

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiangchao Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiangchao Ding. The network helps show where Xiangchao Ding may publish in the future.

Co-authorship network of co-authors of Xiangchao Ding

This figure shows the co-authorship network connecting the top 25 collaborators of Xiangchao Ding. A scholar is included among the top collaborators of Xiangchao Ding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiangchao Ding. Xiangchao Ding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Du, Yifan, Xiangchao Ding, Dashuai Wang, et al.. (2024). Deficiency of ATF3 facilitates both angiotensin II‐induced and spontaneously formed aortic aneurysm and dissection development by activating cGAS–STING pathway. Clinical and Translational Medicine. 15(1). e70147–e70147. 4 indexed citations
2.
Guo, Qiang, et al.. (2022). The Roles and Mechanisms of TRAT1 in the Progression of Non-Small Cell Lung Cancer. Current Medical Science. 42(6). 1186–1200. 8 indexed citations
3.
Ding, Xiangchao, Sheng Le, Yunshu Su, et al.. (2022). Cytosporone B (Csn-B), an NR4A1 agonist, attenuates acute cardiac allograft rejection by inducing differential apoptosis of CD4+T cells. International Immunopharmacology. 104. 108521–108521. 4 indexed citations
4.
Ding, Xiangchao, Dan Cheng, Bing Sun, et al.. (2022). Nomogram and risk calculator for severe hypoxemia after heart valve surgery. Frontiers in Cardiovascular Medicine. 9. 972449–972449. 2 indexed citations
5.
Guo, Qiang, Chuangyan Wu, Dan Li, et al.. (2022). Clinical Roles of Risk Model Based on Differentially Expressed Genes in Mesenchymal Stem Cells in Prognosis and Immunity of Non-small Cell Lung Cancer. Frontiers in Genetics. 13. 823075–823075. 10 indexed citations
6.
Wang, Dashuai, Xiangchao Ding, Yunshu Su, et al.. (2022). Incidence, Risk Factors, and Outcomes of Severe Hypoxemia After Cardiac Surgery. Frontiers in Cardiovascular Medicine. 9. 934533–934533. 8 indexed citations
8.
Huang, Yajun, Sufei Wang, Xiangchao Ding, et al.. (2020). Inhibition of S-adenosyl-L-homocysteine hydrolase alleviates alloimmune response by down-regulating CD4+ T-cell activation in a mouse heart transplantation model. Annals of Translational Medicine. 8(23). 1582–1582. 8 indexed citations
9.
Le, Sheng, Xiaofan Huang, Shu Chen, et al.. (2020). PKM2 Activator TEPP-46 Attenuates Thoracic Aortic Aneurysm and Dissection by Inhibiting NLRP3 Inflammasome-Mediated IL-1β Secretion. Journal of Cardiovascular Pharmacology and Therapeutics. 25(4). 364–376. 35 indexed citations
10.
Chen, Shanshan, Ping Ye, Chuangyan Wu, et al.. (2020). Trametinib alleviates lipopolysaccharide-induced acute lung injury by inhibiting the MEK-ERK-Egr-1 pathway. International Immunopharmacology. 80. 106152–106152. 14 indexed citations
12.
Zhang, Hao, Xiaoyu Qi, Jie Wu, et al.. (2019). BCL6 inhibitor FX1 attenuates inflammatory responses in murine sepsis through strengthening BCL6 binding affinity to downstream target gene promoters. International Immunopharmacology. 75. 105789–105789. 12 indexed citations
13.
Chen, Shanshan, Yuanyuan Zhao, Jinbao Huang, et al.. (2019). TROVE2 strengthens the anti-inflammatory effect via macrophage polarization by estrogen induction in abdominal aortic aneurysm. Life Sciences. 242. 117207–117207. 6 indexed citations
14.
15.
Xiang, Mei, Hongbo R. Luo, Jia Wu, et al.. (2018). ADAM23 in Cardiomyocyte Inhibits Cardiac Hypertrophy by Targeting FAK‐AKT Signaling. Journal of the American Heart Association. 7(18). e008604–e008604. 18 indexed citations
16.
Ding, Xiangchao, Jiuling Chen, Chuangyan Wu, et al.. (2018). Nucleotide‐Binding Oligomerization Domain‐Like Receptor Protein 3 Deficiency in Vascular Smooth Muscle Cells Prevents Arteriovenous Fistula Failure Despite Chronic Kidney Disease. Journal of the American Heart Association. 8(1). e011211–e011211. 13 indexed citations
17.
Huang, Xiaofan, Yue Zhang, Jia Wu, et al.. (2018). MicroRNA-21 Knockout Exacerbates Angiotensin II–Induced Thoracic Aortic Aneurysm and Dissection in Mice With Abnormal Transforming Growth Factor-β–SMAD3 Signaling. Arteriosclerosis Thrombosis and Vascular Biology. 38(5). 1086–1101. 59 indexed citations
18.
Wu, Chuangyan, Xiangchao Ding, Cheng Zhou, et al.. (2017). Inhibition of intimal hyperplasia in murine aortic allografts by administration of a small-molecule TLR4 inhibitor TAK-242. Scientific Reports. 7(1). 15799–15799. 12 indexed citations
19.
Zhang, Anchen, Ke Wang, Cheng Zhou, et al.. (2016). Knockout of microRNA-155 ameliorates the Th1/Th17 immune response and tissue injury in chronic rejection. The Journal of Heart and Lung Transplantation. 36(2). 175–184. 40 indexed citations
20.
Sun, Yuan, Ke Wang, Ping Ye, et al.. (2016). MicroRNA-155 Promotes the Directional Migration of Resident Smooth Muscle Progenitor Cells by Regulating Monocyte Chemoattractant Protein 1 in Transplant Arteriosclerosis. Arteriosclerosis Thrombosis and Vascular Biology. 36(6). 1230–1239. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026